Business Context and Reporting Period
This Form 8-K was filed by N2OFF, Inc. (trading symbol: NITO) on March 17, 2025, reporting events occurring on March 12, 2025. The registrant is a Nevada corporation and an emerging growth company headquartered in Israel. The filing discloses the entry into a material loan agreement.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The specific financial event reported is a new loan extension:
- Loan Principal: $250,000
- Borrower: MitoCareX Bio Ltd.
- Guarantor: L.I.A. Pure Capital Ltd.
- Interest Rate: Annual rate per Section 3(j) of the Israel Income Tax Ordinance (USD exchange rate fluctuation plus 3%).
- Term: Six months.
- Repayment: Principal and accrued interest due at maturity.
Material Changes and Related Transactions
This loan follows a similar $250,000 loan provided to MitoCareX on December 22, 2024. The current loan is intended to finance MitoCareX's ongoing costs until the closing of a securities purchase and exchange agreement entered into on February 25, 2025. That transaction is subject to stockholder approval. If MitoCareX becomes a subsidiary of N2OFF, Inc., any outstanding loan amount will be deducted from future allocations to MitoCareX in the first year following the transaction.
Outlook, Risks, and Contingencies
The filing indicates that the closing of the broader securities purchase and exchange agreement is contingent upon obtaining stockholder approval. The loan serves as a bridge financing mechanism pending this closing. No specific forward-looking guidance or risk factors beyond the transaction contingencies are detailed in this specific report.
Investor Verification Checklist
- Verify the status of the stockholder approval required for the February 25, 2025 securities purchase and exchange agreement.
- Confirm the total outstanding exposure to MitoCareX, including the December 2024 loan and this March 2025 loan.
- Review the full text of the Loan Agreement (Exhibit 10.1) for specific default provisions and interest calculation mechanics.
- Assess the financial health of the guarantor, L.I.A. Pure Capital Ltd.